| CAS登錄號(hào) | 中文名 | 英文名 | 分子結(jié)構(gòu)式 | 分子式 | 詳情 | 供應(yīng)商 |
| 52712-76-2 | 鹽酸布那唑嗪; 1-[4-(4-氨基-6,7-二甲氧基喹唑啉-2-基)-1,4-二氮雜環(huán)庚烷-1-基]丁-1-酮鹽酸鹽 | Bunazosin hydrochloride; 1-[4-(4-Amino-6,7-dimethoxyquinazolin-2-yl)-1,4-diazepan-1-yl]butan-1-one hydrochloride |  | C19H28ClN5O3 | 詳情 | 供應(yīng)商 |
| 55186-89-5 | 1-芐基-1,4-二氮雜環(huán)庚-5-酮 | 1-Benzyl-1,4-diazepan-5-one; 1-Benzyl-2,3,6,7-tetrahydro-(1H)-1,4-diazepin-5(4H)-one |  | C12H16N2O | 詳情 | 供應(yīng)商 |
| 112275-50-0 | 1-Boc-高哌嗪; 1,4-二氮雜環(huán)庚烷-1-甲酸叔丁酯 | 1-Boc-hexahydro-1,4-diazepine; 1-Boc-homopiperazine; tert-Butyl 1,4-diazepane-1-carboxylate; tert-Butyl homopiperazine-1-carboxylate |  | C10H20N2O2 | 詳情 | 供應(yīng)商 |
| 3320-33-0 | 1,3-二(3-異氰酸基-4-甲基苯基)-1,3-二氮雜環(huán)丁烷-2,4-二酮 | 3-Diazetidine-2,4-dione, 1,3-bis(3-isocyanato-4-methylphenyl)-1 |  | C18H12N4O4 | 詳情 | 供應(yīng)商 |
| 17589-24-1 | 1,3-二[4-[(4-異氰酸根苯基)甲基]苯基]-1,3-二氮雜環(huán)丁烷-2,4-二酮 | 1,3-bis[4-[(4-Isocyanatophenyl)methyl]phenyl]-1,3-diazetidine-2,4-dione; 3-Diazetidine-2,4-dione, 1,3-bis[4-[(4-isocyanatophenyl)methyl]phenyl]-1; 4-dione, 1,3-bis[4-[(4-isocyanatophenyl)methyl]phenyl]-3-diazetidine-2 |  | C30H20N4O4 | 詳情 | 供應(yīng)商 |
| 26747-90-0 | 1,3-雙(3-異氰酸根甲基苯基)-1,3-二氮雜環(huán)丁烷-2,4-二酮 | 1,3-bis(3-isocyanatomethylphenyl)-1,3-Diazetidine-2,4-dione; Toluene diisocyanate dimer; 4-dione, 1,3-bis(3-isocyanatomethylphenyl)-3-diazetidine-2; 4-dione,1,3-bis(3-isocyanatomethylphenyl)-3-diazetidine-2 |  | C18H12N4O4 | 詳情 | 供應(yīng)商 |
| 23501-81-7 | 1,3-雙(6-異氰酸己基)-1,3-二氮雜環(huán)丁烷-2,4-二酮 | 3-Diazetidine-2, 4-dione, 1, 3-bis(6-isocyanatohexyl)-1; 4-dione, 1,3-bis(6-isocyanatohexyl)-3-diazetidine-2 |  | C16H24N4O4 | 詳情 | 供應(yīng)商 |
| 31107-36-5 | 1,3-雙[4-[(4-異氰酸根合苯基)甲基]苯基]-4-[[4-[(4-異氰酸根合苯基)甲基]苯基]亞氨基]-1,3-二氮雜環(huán)丁烷-2 | 1,3-di[4-[(p-Isocyanatophenyl) methyl]phenyl]-4-[[4-[(p-isocyanatophenyl) methyl]phenyl]imino]-2-ure; Isocyanicacid, triester with 1,3-bis[a-(p-hydroxyphenyl)-p-tolyl]-4-[[a-(p-hydroxyphenyl)-p-tolyl]imino]-2-uretidinone (8CI); 2-Uretidinone, 1,3-bis[a-(p-hydroxyphenyl)-p-tolyl]-m-[[a-(p-hydroxyphenyl)-p-tolyl]imino]-,triisocyanate (ester) (8CI); 1,3-Bis[4-(4-isocyanatobenzyl)phenyl]-4-[[4-(4-isocyanatobenzyl)phenyl]imino]uretidin-2-one |  | C44H30N6O4 | 詳情 | 供應(yīng)商 |
| 23370-68-5 | 1,3-雙[(5-異氰酸根-1,3,3-三甲基環(huán)己基)甲基]-1,3-二氮雜環(huán)丁烷-2,4-二酮 | N,N'-bis(5-Isocyanato-1,3,3-trimethylcyclohexylmethyl)-1,3-diaza-2,4-dioxocyclobutane; 1,3-diazetidine-2,4-dione, 1,3-bis[(5-isocyanato-1,3,3-trimethylcyclohexyl)meth; 4-dione,1,3-bis[(5-isocyanato-1,3,3-trimethylcyclohexyl)methyl]-3-diazetidine-2 |  | C24H36N4O4 | 詳情 | 供應(yīng)商 |
| 85099-51-0 | 2,2,4,4-四甲基-21-氧代-7-氧雜-3,20-二氮雜環(huán)雙螺[5.1.11.2]-二十一碳烷-20-丙酸十二烷基酯 | 7-Oxa-3,20-diazadispiro [5,1, 11,2] heneicosane-20-propanoic acid,2,2,4,4-tetramethyl-21-oxo-,dodecy | 無(wú) | 詳情 | 供應(yīng)商 | |
| 85099-50-9 | 2,2,4,4-四甲基-21-氧代-7-氧雜-3,20-二氮雜環(huán)雙螺[5.1.11.2]二十一碳烷-20-丙酸十四烷基酯 | 7-Oxa-3,20-diazadispiro (5,1, 11, 2) heneicosane-20-propanoic acid,2,2,4,4-tetramethyl-21-oxo-,tetra; 7-oxa-3,20-diazadispiro[5.1.11.2]heneicosane-20-propanoic acid, 2,2,4,4-tetrame | 無(wú) | 詳情 | 供應(yīng)商 | |
| 22777-05-5 | 5-甲基-[1,4]二氮雜環(huán)庚烷 | 1H-1,4-Diazepine,hexahydro-5-methyl-; 5-Methyl-[1,4]diazepane |  | C6H14N2 | 詳情 | 供應(yīng)商 |
| 194032-42-3 | 5-甲基-1,4-二氮雜環(huán)庚烷-1-甲酸叔丁酯 | 1H-1,4-Diazepine-1-carboxylicacid, hexahydro-5-methyl-, 1,1-dimethylethyl ester; Hexahydro-5-methyl-1H-1,4-diazepine-1-carboxylic acid 1,1-dimethylethyl ester |  | C11H22N2O2 | 詳情 | 供應(yīng)商 |
| 23978-55-4 | 1,4,10,13-四氧雜-7,16-二氮雜環(huán)十八烷; 1,10-二氮雜-18-冠醚-6 | 1,4,10,13-Tetraoxa-7,16-diazacyclooctadecane; 1,10-Diaza-18-crownether; 1,10-Diaza-18-crown-6; 1,10-Diaza-4,7,13,16-tetraoxa-18-crown-6; 1,10-Diaza-4,7,13,16-tetraoxacyclooctadecane; 1,7,10,16-Tetraoxa-4,13-diazacyclooctadecane; 2,2'-Kryptofix; 4,13-Diaza-18-crown-6; 4,7,13,16-Tetraoxa-1,10-diazacyclooctadecane; 7,16-Diaza-1,4,10,13-tetraoxacyclooctadecane; 7,16-Diaza-18-crown-6; Cryptand22; Cryptand(2.2); Crytand[2,2]; Diaza crown ether 22; Diaza-18-crown-6; Kryptand[2.2]; Kryptofix 22; Kryptofix[2.2]; NSC 339325 |  | C12H26N2O4 | 詳情 | 供應(yīng)商 |
| 3619-70-3 | 1-乙基六氫-[1,4]二氮雜環(huán)庚烷-5-酮; 1-乙基六氫-5H-1,4-二氮雜卓-5-酮 | 5H-1,4-Diazepin-5-one,1-ethylhexahydro-; 1-Ethylhexahydro-5H-1,4-diazepin-5-one |  | C7H14N2O | 詳情 | 供應(yīng)商 |
| 880362-05-0 | 1-[2-(3-甲基吡啶基)]-1,4-二氮雜環(huán)庚烷 | 1-(3-METHYL-PYRIDIN-2-YL)-[1,4]DIAZEPANE |  | C11H17N3 | 詳情 | 供應(yīng)商 |
| 21279-57-2 | 1-(2-嘧啶基)-1,4-二氮雜環(huán)庚烷 | 1-PYRIMIDIN-2-YL-1,4-DIAZEPANE; 1-(2-Pyrimidinyl)homopiperazine; 1-Pyrimidin-2-yl-[1,4]diazepane |  | C9H14N4 | 詳情 | 供應(yīng)商 |
| 7327-69-7 | ; 四氫化-3,5-雙(羥甲基)-4H-1,3,5-氧二氮雜環(huán)己烷-4-酮 | tetrahydro-3,5-bis(hydroxymethyl)-4H-1,3,5-oxadiazin-4-one; tetrahydro-3,5-bis(hydroxymethyl)-4H-1,3,5-oxadiazin-4-one; 3,5-Dimethyloluron; 3,5-Bis(hydroxymethyl)tetrahydro-2H-1,3,5-oxadiazin-4-one; Tetrahydro-4-oxo-2H-1,3,5-oxadiazine-3,5-dimethanol; 4H-1,3,5-Oxadiazin-4-one, tetrahydro-3,5-bis(hydroxymethyl)-; Einecs 230-807-5 |  | C5H10N2O4 | 詳情 | 供應(yīng)商 |
| 1071992-99-8 | AT-406; (5S,8S,10AR)-N-(二苯基甲基)十氫-5-[[(2S)-2-(甲基氨基)-1-氧代丙基]氨基]-3-(3-甲基-1-氧代丁基)-6-氧代吡咯并[1,2-A][1,5]二氮雜環(huán)辛烷-8-甲酰胺 | AT-406(AT406); AT-406(AT406); (5S,8S,10aR)-N-benzhydryl-5-((S)-2-(MethylaMino)propanaMido)-3-(3-Methylbutanoyl)-6-oxodecahydropyrrolo[1,2-a][1,5]diazocine-8-carboxaMide; SM 406; (5S,8S,10aR)-N-(Diphenylmethyl)decahydro-5-[[(2S)-2-(methylamino)-1-oxopropyl]amino]-3-(3-methyl-1-oxobutyl)-6-oxopyrrolo[1,2-a][1,5]diazocine-8-carboxamide; AT-406 (SM-406) | 無(wú) | C32H43N5O4 | 詳情 | 供應(yīng)商 |
| 65974-17-6 | 2-甲基-1,4-二氮雜環(huán)庚烷 | 2-Methyl-[1,4]diazepane |  | C6H14N2 | 詳情 | 供應(yīng)商 |